SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
InterMune (nasdaq)ITMN
An SI Board Since March 2000
Posts SubjectMarks Bans Symbol
508 36 0 ITMN
Emcee:  Secret_Agent_Man Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
358Hi, The results were as good as could be reasonably expected. 2003 guidance maIRWIN JAMES FRANKEL-2/19/2003
357IJ, Given the afterhours action, did ITMN reduce the low- or high- end of 2003 quidditch-2/19/2003
356InterMune Announces Fourth Quarter and Year End Financial Results Wednesday FebrIRWIN JAMES FRANKEL-2/19/2003
355InterMune (ticker: ITMN, exchange: NASDAQ) News Release - 2/4/03 -------------IRWIN JAMES FRANKEL-2/4/2003
354Press Release Source: InterMune, Inc. InterMune Names Thomas R. Hodgson to BoaIRWIN JAMES FRANKEL-2/3/2003
353Hi Mike, "The actimmune extension data suggest the drug provides minimal, IRWIN JAMES FRANKEL-1/25/2003
352Scott Harkonen must be down. He's a "patients first" biotech manascaram(o)uche-1/25/2003
351Interesting. Frankly, I doubt pirfenidone will work any better than actimmune. Michael Young-1/25/2003
350fightingpulmonaryfibrosis.org Unsettling suit against itmn.ewolf-1/25/2003
349>>BRISBANE, Calif., Jan. 23 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nastuck-1/23/2003
34801/17 09:32 InterMune EPS Estimates, Price Target Cut at Banc of America By SybiIRWIN JAMES FRANKEL-1/19/2003
347>>8:37AM InterMune: Morgan Stanley taking conservative stance on earnings tuck-1/7/2003
346The take from Mr. Gothcha (as he is occasionally known here): >>Doubts Sutuck-1/7/2003
345Press Release Source: InterMune, Inc. InterMune to Update Investors at the 21sIRWIN JAMES FRANKEL-1/7/2003
344> Does anyone hear ... Ugh. "here". Sorry. Wish SI had a homophonlrb-12/22/2002
343As I recall, on the CC following the release of the trial results in late Augustlrb-12/22/2002
342OT Pardon me for the curiosity but how did you become afflicted with the crazy gewolf-12/7/2002
341<the apparent advantage of Infergen as vs. Rebetron is enhanced when ribaviriIRWIN JAMES FRANKEL-11/5/2002
340<Dr. Sjogren and colleagues reported that all patients in the study received quidditch-11/5/2002
339The PIV Infergen data appears to be as good or better in producing SVR than Peg-IRWIN JAMES FRANKEL-11/5/2002
338Morning quid, CHEST is going on now in San Diego. I think tomorrow the presentIRWIN JAMES FRANKEL-11/5/2002
337Thanks, IJ, What is the date of the CHEST meeting, at which further analysis ofquidditch-11/5/2002
336InterMune Announces Phase IV Study Shows Infergen Combination Therapy More EffecIRWIN JAMES FRANKEL-11/5/2002
335Hi wolf, No apology is necessary. I just wanted to know if I was missing sometIRWIN JAMES FRANKEL-10/29/2002
334I'm sorry. Memory doesn't work. I believe it was the Three Rivers actionewolf-10/29/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News